Kathrine Abell
- Molecular Biology
- Oncology top 10%
- Immunology top 10%
- Cancer Research
- Cellular and Molecular Neuroscience
- Co-authors
- Christine J. WatsonRichard ClarksonKlaus BendtzenÉlizabeth AndersonAndrew SharkeyEkaterini A. KritikouEwan J.D. RobsonWalid T. Khaled
- Topics
- Mitochondrial Function and Pathology (3 papers)Genetic Neurodegenerative Diseases (3 papers)Monoclonal and Polyclonal Antibodies Research (3 papers)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- DenmarkUnited KingdomJapan
In The Last Decade
Kathrine Abell
15 papers receiving 800 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 349
- Oncology 305
- Immunology 227
- Cancer Research 147
- Cellular and Molecular Neuroscience 91
Countries citing papers authored by Kathrine Abell
This map shows the geographic impact of Kathrine Abell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrine Abell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrine Abell more than expected).
Fields of papers citing papers by Kathrine Abell
This network shows the impact of papers produced by Kathrine Abell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrine Abell. The network helps show where Kathrine Abell may publish in the future.
Co-authorship network of co-authors of Kathrine Abell
This figure shows the co-authorship network connecting the top 25 collaborators of Kathrine Abell. A scholar is included among the top collaborators of Kathrine Abell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrine Abell. Kathrine Abell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 28 | |
| 3 | 86 | |
| 4 | 61 | |
| 5 | 80 | |
| 6 | 43 | |
| 7 | 92 | |
| 8 | 18 | |
| 9 | 158 | |
| 10 | 29 | |
| 11 | 50 | |
| 12 | 35 | |
| 13 | Interleukin-6 autoantibodies: possible biological and clinical significance. | 18 |
| 14 | 36 | |
| 15 | 69 |
About Kathrine Abell
Kathrine Abell is a scholar working on Cancer Research, Immunology and Immunology and Allergy, having authored 15 papers that have together received 813 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (3 papers), Genetic Neurodegenerative Diseases (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Oncology (305 citations), Immunology (227 citations) and Cancer Research (147 citations). Kathrine Abell has collaborated with scholars based in Denmark, United Kingdom and Japan. Frequent co-authors include Christine J. Watson, Richard Clarkson, Klaus Bendtzen, Élizabeth Anderson, Andrew Sharkey, Ekaterini A. Kritikou, Ewan J.D. Robson, Walid T. Khaled, Morten Svenson and Morten Bagge Hansen. Their work appears in journals such as Nature Cell Biology, Development and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.